Paper40116950
Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions.
Chan YL and 4 others. Appl Microbiol Biotechnol, 2025. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions. Papers, record 40116950. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40116950
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Bifidobacterium lactis ameliorates AOM/DSS-induced inflammation, dysbiosis, and colonic precancerous lesions.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dysbiosis | Major topic |
| Probiotics | Major topic |
| Precancerous Conditions | Major topic |
| Inflammation | Major topic |
| Bifidobacterium animalis | Major topic |
| Colonic Neoplasms | Major topic |
| Animals | |
| Mice, Inbred C57BL | |
| Female | |
| Dextran Sulfate | |
| Azoxymethane | |
| Gastrointestinal Microbiome | |
| Mice | |
| Disease Models, Animal | |
| Colon | |
| Cytokines |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MOST 109-2320-B-031-001 | Ministry of Science and Technology | PubMed |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20011296 | Colorectal cancer: epidemiology, risk factors, and health services. | Clin Colon Rectal Surg | 2005 | https://conductscience.org/library/papers/20011296 | PubMed |
| 2 | 34315530 | Induction of colorectal carcinogenesis in the C57BL/6J and A/J mouse strains with a reduced DSS dose in the AOM/DSS model. | Lab Anim Res | 2021 | https://conductscience.org/library/papers/34315530 | PubMed |
| 3 | 24695404 | Trimmomatic: a flexible trimmer for Illumina sequence data. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24695404 | PubMed |
| 4 | 17350461 | Allelic losses at genomic instability-associated loci in villous adenomas and adjacent colorectal cancers. | Cancer Genet Cytogenet | 2007 | https://conductscience.org/library/papers/17350461 | PubMed |
| 5 | 12615608 | Heterocyclic amines, meat intake, and association with colon cancer in a population-based study. | Am J Epidemiol | 2003 | https://conductscience.org/library/papers/12615608 | PubMed |
| 6 | 27214047 | DADA2: High-resolution sample inference from Illumina amplicon data. | Nat Methods | 2016 | https://conductscience.org/library/papers/27214047 | PubMed |
| 7 | 34980222 | Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/34980222 | PubMed |
| 8 | 34970580 | Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review. | Front Nutr | 2021 | https://conductscience.org/library/papers/34970580 | PubMed |
| 9 | 22335359 | The potential of bifidobacteria as a source of natural folate. | J Appl Microbiol | 2012 | https://conductscience.org/library/papers/22335359 | PubMed |
| 10 | 28690172 | Managing colonic inflammation associated gut derangements by systematically optimised and targeted ginger extract-Lactobacillus acidophilus loaded pharmacobiotic alginate beads. | Int J Biol Macromol | 2017 | https://conductscience.org/library/papers/28690172 | PubMed |
| 11 | 35967843 | Antibiotic and antifungal use in pediatric leukemia and lymphoma patients are associated with increasing opportunistic pathogens and decreasing bacteria responsible for activities that enhance colonic defense. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/35967843 | PubMed |
| 12 | 26992426 | Tumour-associated and non-tumour-associated microbiota in colorectal cancer. | Gut | 2017 | https://conductscience.org/library/papers/26992426 | PubMed |
| 13 | 31610204 | Probiotic supplementation attenuates the aggressiveness of chemically induced colorectal tumor in rats. | Life Sci | 2019 | https://conductscience.org/library/papers/31610204 | PubMed |
| 14 | 35996962 | Colon microbiota modulation by dairy-derived diet: new strategy for prevention and treatment of colorectal cancer. | Food Funct | 2022 | https://conductscience.org/library/papers/35996962 | PubMed |
| 15 | 28786406 | Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. | Am J Gastroenterol | 2017 | https://conductscience.org/library/papers/28786406 | PubMed |
| 16 | 32075595 | Rectal aberrant crypt foci (ACF) as a predictor of benign and malignant neoplastic lesions in the large intestine. | BMC Cancer | 2020 | https://conductscience.org/library/papers/32075595 | PubMed |
| 17 | 31905929 | Synbiotic Combination of Djulis (Chenopodium formosanum) and Lactobacillus acidophilus Inhibits Colon Carcinogenesis in Rats. | Nutrients | 2019 | https://conductscience.org/library/papers/31905929 | PubMed |
| 18 | 31717536 | Lactobacillus acidophilus-Fermented Germinated Brown Rice Suppresses Preneoplastic Lesions of the Colon in Rats. | Nutrients | 2019 | https://conductscience.org/library/papers/31717536 | PubMed |
| 19 | 19114073 | Different effects of probiotic species/strains on infections in preschool children: A double-blind, randomized, controlled study. | Vaccine | 2009 | https://conductscience.org/library/papers/19114073 | PubMed |
| 20 | 35952517 | Natural shikonin and acetyl-shikonin improve intestinal microbial and protein composition to alleviate colitis-associated colorectal cancer. | Int Immunopharmacol | 2022 | https://conductscience.org/library/papers/35952517 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42603252 | Melatonin Ameliorates Neuropathic Pain in Mice by Regulating Pyroptosis Through Gut Microbiota-Mediated Linoleic Acid. | Mol Neurobiol | 2026 | https://conductscience.org/library/papers/42603252 | PubMed |
| 41953220 | Probiotics and human health: biological activities, nutritional aspects, immunomodulatory properties, applications, and future perspectives - a comprehensive review. | Front Immunol | 2025 | https://conductscience.org/library/papers/41953220 | PubMed |
| 41922785 | Polydopamine cross-linked Bifidobacterium single cell core-shell system with multi-target regulation to alleviate constipation in mice. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/41922785 | PubMed |
| 41372345 | Dynamic stability analysis of a fractional calculus-based colon cancer model with therapeutic interventions. | Sci Rep | 2025 | https://conductscience.org/library/papers/41372345 | PubMed |
| 41134485 | The Potential Anticancer Mechanisms of Probiotics: A Comprehensive Review. | Probiotics Antimicrob Proteins | 2026 | https://conductscience.org/library/papers/41134485 | PubMed |
| 40869174 | Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869174 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40116950
GET https://conductscience.org/api/papers/v1/40116950/references?page=2